Epidemiology of Diabetic Foot and Management of Foot Problems in India

Abstract

Diabetes the global epidemic is rapidly increasing at an alarming rate. Developing countries like India harbor the majority of diabetic people and by the year 2030 AD India will have the largest number of diabetic patients. Diabetic foot is one of the common diabetic complications found in India. Both aerobic and anaerobic pathogens form the etiology for diabetic foot infection. Members of the Enterobacteriaceae family were the most prominent among the aerobes while members of the Genus Peptostreptococcus and Clostridium were most prominent among the anaerobes. Ulcers infected with anaerobic pathogens showed a longer healing time than ulcers infected with aerobic pathogens. Oxidative stress is one of the major markers of inflammatory response and oxidative stress markers such as lipid peroxidation, thiobarbituric acid reactive substance (TBARS), Superoxide Dismutase (SOD), Catalase, G Peroxidase, G-S Peroxidase and plasma total antioxidant play a major role in the nonhealing of diabetic foot ulcers. Growth factors such as platelet-derived growth factor (PDGF), transforming growth factor (VEGF), and epidermal growth factor (EGF) are needed for normal wound repair, while proteases such as matrix metalloproteinase (MMP) and serine proteases found in chronic wounds delay the healing process.

Keywords

diabetic foot epidemiology India

Get full access to this article

View all access options for this article.

References

Apelqvist J. , Bakker K. , van Houtum WH , Schaper NC The development of global consensus guidelines on the management of the diabetic foot. Diabetes Metab Res Rev. 2008; 24(Suppl 1):S116-S118.

Armstrong DG , Lavery LA , Harkless LB Validation of a diabetic wound classification system. The contribution of depth, infection, and ischemia to risk of amputation . Diabetes Care. 1998 ;21:855-859.

Clinical Guidelines Task Force. Guide for Guidelines: A Guide for Clinical Guideline Development. Brussels, Belgium: International Diabetes Federation ; 2003.

Van Houtum WH Barriers to the delivery of diabetic foot care . Lancet. 2005;366:1678-1679.

International Diabetes Federation. IDF Atlas. 4th ed. Brussels , Belgium: International Diabetes Federation; 2009.

Wild S. , Roglic G. , Green A. , Sicree R. , King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047-1053.

Popkin BM , Gordon-Larsen P. The nutrition transition: worldwide obesity dynamics and their determinants . Int J Obes Relat Metab Disord. 2004;28(Suppl 3):S2-S9.

Unwin N. The diabetic foot in the developing world. Diabetes Metab Res Rev. 2008;24(Suppl 1):S31-S33.

Jeffcoate WJ , Harding KG Diabetic foot ulcers. Lancet . 2003;361:1545-1551.

10.

Boulton AJ , Vileikyte L. , Ragnarson-Tennvall G. , Apelqvist J. The global burden of diabetic foot disease. Lancet . 2005;366: 1719-1724.

11.

Oyibo SO , Jude EB , Tarawneh I. , et al. The effect of ulcer size and site, patient’s age, sex and type and duration of diabetes on the outcome of diabetic foot ulcers. Diabet Med. 2001;18:133-138.

12.

Apelqvist J. , LarssonJ, Agardh CD Long-term prognosis for diabetic patients with foot ulcers. J Intern Med. 1993;233: 485-491.

13.

Jeffcoate WJ , Chipchase SY , Ince P. , Game FL Assessing the outcome of the management of diabetic foot ulcers using ulcer-related and person-related measures. Diabetes Care. 2006;29:1784-1787.

14.

Viswanathan V. , Thomas N. , Tandon N. , et al. Profile of diabetic foot complications and its associated complications: a multicentric study from India. J Assoc Physicians India. 2005;53:933-936.

15.

Vijay V. , Snehalatha C. , Terin M. , Ramachandran A. Socio-cultural practices that may affect the development of the diabetic foot . IDF Bull. 1997:42;10-12.

16.

Viswanathan V. The diabetic foot: Perspectives from Chennai, south India. Int J Lower Extrem Wounds. 2007 ;6: 34-36.

17.

Viswanathan V. , Sivagami, Rajasekar S. Diabetic foot: An Indian scenario . Asian J Diabetol. 2005;7(3):9-11.

18.

Viswanathan V. , Kumpatla S. ; Indian Diabetic Amputation Study Group. Patterns and causes of amputation in diabetic patients: A multicentre study from India. JAPI (in press).

19.

Morbach S. , Lutalet JK , Viswanathan V. , et.al. Regional differences in risk factors and clinical presentation of diabetic foot lesions. Diabet Med. 2004 ;21:91-95.

20.

V. Viswanathan , Jasmine JJ , Snehalatha C. , Ramachandran A. Prevalence of pathogens in diabetic foot infection in south Indian type 2 diabetic patients . J Assoc Physicians India. 2002;50:1013-1016.

21.

Viswanathan V. , Narasimhan DVL , Seena R. , et al. Clinical profile of diabetic foot infection in south India: a retrospective study. Diabet Med . 2000;17:215-218.

22.

Vairamon S. , Babu M. , Viswanathan V. Oxidative stress markers regulating the healing of diabetic foot ulcers in patients with type 2 diabetes . Wounds. 2009;21:273-279.

23.

Viswanathan V. , Kumpatla S. , Gnanasundaram S. , Gopanakrishna G. , Das B. Assessment of ulcer related outcomes in type 2 diabetic patients with foot ulceration in India . J Diabet Foot Complicat. 2009;1. http://jdfceditors.wordpress.com/2009/06/30/assessment-of-ulcer-related-outcomes-in-type-2-diabetic-patients-with-foot-ulceration-in-india/ . Accessed July 13, 2010.

24.

Viswanathan V. , Sivagami M. , Seena R. , Snehalatha C. , Ramachandran A. Amputation prevention initiative in south India: Positive impact of foot care education . Diabetes Care . 2005;28:1019-1021.

25.

Abraham JA , Klagsbrun M. Modulation of wound repair by members of the fibroblast growth factor family . Mol Cell Biol Wound Repair. 1996 ;2:195-248.

26.

Treating Diabetic Foot: Express Healthcare. http://www.expresshealthcaremgmt.com/200909/knowledge01.shtml. Accessed July 13, 2010.

27.

Tsang MW , Wong WK , Hung CS , Lai KM , Tang W. , Cheung EYN. Human epidermal growth factor enhances healing of diabetic foot ulcers . Diabetes Care. 2003;26: 1856-1861.

28.

Vijay V. , Sharad P. , Sekar N. , Murthy GSR. A phase III study to evaluate the safety and efficacy of recombinant human epidermal growth factor (REGEN-DTM 150) in healing diabetic foot ulcers . Wounds. 2006;18:186-196.